Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura-Reference-Cited by-同舟云学术

Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura

Published:2001-03 Issue:3 Volume:112 Page:637-640
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Fabris F.,Tassan T.,Ramon R.,Carraro G.,Randi M. L.,Luzzatto G.,Moschino P.,Girolami A.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02615.x/fullpdf

Reference12 articles.

1. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura;Cortellazzo;Blood,1991

2. High dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura;Fabris;New England Journal of Medicine,1997

3. Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura;Fenaux;European Journal of Haematology,1989

4. Treatment options for chronic idiopathic (immune) thrombocytopenic purpura;George;Seminars in Hematology,2000

5. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology;George;Blood,1996

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response;Journal of Internal Medicine;2023-11-13

2. Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response;British Journal of Haematology;2023-10-11

3. Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective;Annals of Hematology;2023-05-12

4. Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia;International Journal of Molecular Sciences;2023-02-23

5. Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment;American Journal of Hematology;2021-10-26